Meyka Pro banner
Accendra Health, Inc.

Accendra Health, Inc. Fundamental Analysis (NYSE: ACH)

ACH●NYSE
HealthcareMedical - Distribution
$0.02
$0.001(3.50%)
U.S. Market opens in 51h 34m

Accendra Health, Inc. Fundamental Analysis (NYSE: ACH)

Accendra Health, Inc. (NYSE: ACH) shows moderate financial fundamentals with a PE ratio of -0.01, profit margin of -6.72%, and ROE of 33.56%. The company generates $2.6B in annual revenue with weak year-over-year growth of -74.19%.

Key Strengths

ROE33.56%
Cash Position1792.58%
PEG Ratio-0.00

Areas of Concern

Operating Margin1.60%
Current Ratio0.41
We analyze ACH's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -7.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-7.8/100

We analyze ACH's fundamental strength across five key dimensions:

Efficiency Score

Weak

ACH struggles to generate sufficient returns from assets.

ROA > 10%
-8.25%

Valuation Score

Excellent

ACH trades at attractive valuation levels.

PE < 25
-0.01
PEG Ratio < 2
-0.00

Growth Score

Weak

ACH faces weak or negative growth trends.

Revenue Growth > 5%
-74.19%
EPS Growth > 10%
-2.03%

Financial Health Score

Moderate

ACH shows balanced financial health with some risks.

Debt/Equity < 1
-3.26
Current Ratio > 1
0.41

Profitability Score

Weak

ACH struggles to sustain strong margins.

ROE > 15%
33.56%
Net Margin ≥ 15%
-6.72%
Positive Free Cash Flow
No

Key Financial Metrics

Is ACH Expensive or Cheap?

P/E Ratio

ACH trades at -0.01 times earnings. This suggests potential undervaluation.

-0.01

PEG Ratio

When adjusting for growth, ACH's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Accendra Health, Inc. at -0.00 times its book value. This may indicate undervaluation.

-0.00

EV/EBITDA

Enterprise value stands at -12.92 times EBITDA. This is generally considered low.

-12.92

How Well Does ACH Make Money?

Net Profit Margin

For every $100 in sales, Accendra Health, Inc. keeps $-6.72 as profit after all expenses.

-6.72%

Operating Margin

Core operations generate 1.60 in profit for every $100 in revenue, before interest and taxes.

1.60%

ROE

Management delivers $33.56 in profit for every $100 of shareholder equity.

33.56%

ROA

Accendra Health, Inc. generates $-8.25 in profit for every $100 in assets, demonstrating efficient asset deployment.

-8.25%

Following the Money - Real Cash Generation

Operating Cash Flow

Accendra Health, Inc. generates limited operating cash flow of $-25.33M, signaling weaker underlying cash strength.

$-25.33M

Free Cash Flow

Accendra Health, Inc. generates weak or negative free cash flow of $-163.95M, restricting financial flexibility.

$-163.95M

FCF Per Share

Each share generates $-2.13 in free cash annually.

$-2.13

FCF Yield

ACH converts -110.29% of its market value into free cash.

-110.29%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.01

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.001

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-3.26

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.41

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.34

vs 25 benchmark

ROA

Return on assets percentage

-0.08

vs 25 benchmark

ROCE

Return on capital employed

0.03

vs 25 benchmark

How ACH Stacks Against Its Sector Peers

MetricACH ValueSector AveragePerformance
P/E Ratio-0.0130.24 Better (Cheaper)
ROE33.56%540.00% Weak
Net Margin-6.72%-2322.00% (disorted) Weak
Debt/Equity-3.260.08 Strong (Low Leverage)
Current Ratio0.415.59 Weak Liquidity
ROA-8.25%-17516.00% (disorted) Weak

ACH outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Accendra Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-73.16%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-3136.39%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-124.73%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ